SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?


To: Bipin Prasad who wrote (22674)1/20/2000 9:06:00 AM
From: OmertaSoldier  Respond to of 23519
 
From Briefing.com

08:30 ET Vivus Inc (VVUS) 4 27/32: Issue bid up 1 1/2 on news impotence treatment company expects to report blow-out Q4 results of $0.40 to $0.42 a share. The one analysts surveyed by First Call was expecting a loss of $0.05. VVUS attributing strong numbers to additional revenues recorded as part of the resolution of financial obligations related to the return of marketing and distribution rights for MUSE from AstraZeneca.